Category Archive: Cancer

Aug 27 2013

CHOP Researchers Advance New Anti-Tumor Immunotherapy Approach

Children’s Hospital investigators may have developed a completely new type of cancer immunotherapy, one that involves harnessing the body’s immune system to attack tumors.

Permanent link to this article: http://www.research.chop.edu/blog/chop-researchers-advance-new-anti-tumor-immunotherapy-approach/

Aug 15 2013

Presentation, Not Treatment, Responsible for Racial Disparity in Breast Cancer Survival

Researchers from The Children’s Hospital of Philadelphia and the University of Pennsylvania recently published a study in the Journal of the American Medical Association (JAMA) that shows differences in how breast cancer patients present at diagnosis are more responsible for racial disparities in 5-year survival than treatment disparities.

Permanent link to this article: http://www.research.chop.edu/blog/presentation-not-treatment-responsible-for-racial-disparity-in-breast-cancer-survival/

Aug 06 2013

Reprogramming Stem Cells to Treat, Study Disease

In two new studies, investigators from CHOP reprogrammed skin cells from patients with rare disorders into induced pluripotent stem cells (iPSCs).

Permanent link to this article: http://www.research.chop.edu/blog/reprogramming-stem-cells-to-treat-study-disease/

Jul 18 2013

CHOP Immune Therapy Trial Highlighted by Association of American Medical Colleges

On its research advocacy blog Research Means Hope, the Association of American Medical Colleges (AAMC) recently highlighted an innovative immune therapy trial led by researchers from CHOP and Penn that led to the dramatic recovery of one young patient.

Permanent link to this article: http://www.research.chop.edu/blog/chop-immune-therapy-trial-highlighted-by-association-of-american-medical-colleges/

Jul 03 2013

CHOP Cancer Expert Garrett Brodeur Honored with Pediatric Oncology Award and Lecture

The American Society of Clinical Oncology will confer one of its highest awards on Garrett M. Brodeur, MD, who will receive the Pediatric Oncology Award and deliver the Pediatric Oncology Lecture.

Permanent link to this article: http://www.research.chop.edu/blog/chop-cancer-expert-garrett-brodeur-honored-with-pediatric-oncology-award-and-lecture/

Apr 23 2013

Genetic Study Suggests Fine-Tuning Drugs for Pediatric Brain Tumors

A new genetic study offers glimpses into how scientists might use gene-sequencing data to customize pediatric patients’ cancer treatments.

Permanent link to this article: http://www.research.chop.edu/blog/genetic-study-suggests-fine-tuning-drugs-for-pediatric-brain-tumors/

Apr 02 2013

AACR Academy Inaugurates Tom Curran, PhD, FRS into First Class of Fellows

Tom Curran, PhD, FRS, Deputy Scientific Director of The Children’s Hospital of Philadelphia Research Institute, will be formally inducted into the AACR Academy on April 5 in Washington, D.C.

Permanent link to this article: http://www.research.chop.edu/blog/aacr-academy-inaugurates-tom-curran-phd-frs-into-first-class-of-fellows/

Mar 26 2013

Advanced Cell Therapy Eliminates Aggressive Leukemia in Two Children

According to new research from The Children’s Hospital of Philadelphia and the University of Pennsylvania, two children with an aggressive form of childhood leukemia achieved a complete response after being treated with an innovative cell therapy.

Permanent link to this article: http://www.research.chop.edu/blog/advanced-cell-therapy-eliminates-aggressive-leukemia-in-two-children/

Mar 20 2013

CHOP Investigator Sheds Light on Effects of Sequestration on Cancer Research

CHOP’s Peter Adamson, MD, who heads the Children’s Oncology Group, the largest organization in the world dedicated to childhood and adolescent cancer research, was recently interviewed by journalist Paul Goldberg for the March 15 issue of The Cancer Letter.

Permanent link to this article: http://www.research.chop.edu/blog/chop-investigator-sheds-light-on-effects-of-sequestration-on-cancer-research/

Jan 24 2013

Study Shows Neuroblastoma Evolves Rapidly, Limiting Treatment Targets

A recent genomic study of neuroblastoma reinforces the challenges of treating the most aggressive forms of this disease. Contrary to expectations, the researchers found relatively few recurrent gene mutations — mutations that would suggest new targets for neuroblastoma treatment. Instead, the investigators have refocused on how neuroblastoma tumors evolve in response to medicine and other factors.

Permanent link to this article: http://www.research.chop.edu/blog/study-shows-neuroblastoma-evolves-rapidly-limiting-treatment-targets/

Older posts «

» Newer posts